Sunday, May 18, 2025
5/18/2025
Mitochondrial magnesium regulates MCU activity and PTP opening during ischemic reperfusion injury - PROJECT SUMMARY Magnesium (Mg2+) is a ubiquitous intracellular divalent cation and a crucial co-factor in the machinery that replicates, transcribes, and translates genomic information. Like calcium, Mg2+ is compartmentalized to mitochondria, and Mrs2 is the only known molecular machinery associated with mitochondrial Mg2+ influx. Apart from its conventional function of activating enzymes within the TCA cycle and electron transport chain, our previous research showed mitochondrial Mg2+ (mMg2+) to bind the N-terminal domain of the mitochondrial Ca2+ Uniporter (MCU) regulating acidic patch (MRAP) and regulates MCU-mediated mitochondrial Ca2+ (mCa2+) uptake. The overload of mCa2+ is associated with heart failure (HF) and because mMg2+ regulates mCa2+ uptake, we anticipate a loss of mMg2+ homeostasis in ischemic reperfusion (IR) injury, which can overload mCa2+ and predispose the cardiomyocytes to mitochondrial permeability transition pore (mPTP)-mediated cell death. Our preliminary results indicated a significant reduction in mMg2+ uptake in NRVMs exposed to hypoxia/reoxygenation relative to the control. Intriguingly, the decrease in mMg2+ was not due to a decrease in mRNA or protein levels, but rather post-translational modification of Mrs2 by oxidation, resulting in a loss of function. Our preliminary results also showed that the loss of mMg2+ uptake was related to increased mCa2+ overload, bioenergetics crisis, and mPTP opening. To determine whether impaired mMg2+ influx causes mCa2+ overload and mPTP opening, we expressed a cysteine null (Mrs2C269A) mutant in NRVMs. We observed that cysteine nullification rendered Mrs2 insensitive to oxidation and oxidative inhibition, protecting NRVMs from mCa2+ overload-mediated cell death during HR injury. Based on these observations, we hypothesize that oxidative stress inactivates Mrs2, resulting in the loss of mMg2+ uptake. This, in turn, relieves MCU from Mg2+- dependent negative feedback inhibition, ultimately leading to an increase in MCU-mediated mCa2+ overload and making cardiomyocytes more susceptible to mPTP-mediated cell death. To evaluate whether impaired mMg2+ influx is causally linked to mCa2+ overload-mediated cardiomyocyte death and heart failure, we propose three aims: Aim 1: Define the mechanism by which post-translational oxidative modification regulates Mrs2 activity. Aim 2: Investigate the regulatory role of Mrs2 oxidation in cardiac mitochondrial bioenergetics. Aim 3: Define the ionic link between Mrs2 and MCU in regulating cardiac function during IR injury. The completion of the proposed experiments will provide a missing link between the ionic dysregulation and mitochondrial dysfunction hypotheses and advocate targeting mitochondrial ion homeostasis as a powerful therapeutic strategy to inhibit or reverse HF progression, even though the role of mCa2+ overload and mPTP opening in cardiac diseases are already known.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).